YKL40 in sporadic amyotrophic lateral sclerosis: C cerebrospinal fluid levels as a prognosis marker of disease progression (vol 10, pg 2367, 2018)

被引:2
作者
Andres-Benito, Pol [1 ,2 ,3 ]
Dominguez, Raul [4 ]
Colomina, Maria J. [5 ]
Llorens, Franc [2 ,3 ]
Povedano, Monica [4 ]
Ferrer, Isidre [1 ,2 ,3 ,6 ,7 ]
机构
[1] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
[2] Inst Carlos III, Biomed Network Res Ctr Neurodegenerat Dis CIBERNE, Barcelona, Spain
[3] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
[4] Bellvitge Univ Hosp, Serv Neurol, Funct Unit Amyotroph Lateral Sclerosis UFELA, Barcelona, Spain
[5] Univ Barcelona, Bellvitge Univ Hosp, Anesthesia & Crit Care Dept, Barcelona, Spain
[6] IDIBELL, Bellvitge Univ Hosp, Serv Anat Pathol, Neuropathol, Barcelona, Spain
[7] Univ Barcelona, Inst Neurosci, Barcelona, Spain
来源
AGING-US | 2021年 / 13卷 / 20期
关键词
D O I
10.18632/aging.203667
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:23871 / 23871
页数:1
相关论文
共 1 条
[1]   YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression [J].
Andres-Benito, Pol ;
Dominguez, Raul ;
Colomina, Maria J. ;
Llorens, Franc ;
Povedano, Monica ;
Ferrer, Isidre .
AGING-US, 2018, 10 (09) :2367-2382